Skip to main content

Animations

MJFF Publications

4631 - 4640 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2021
  • 2025
  • 2025
  • 2025
  • 2023
  • 2023
  • 2023
  • 2022
  • Summary Details
    OPEN
    Title: Protective Factors That Maintain Asymptomatic Longevity in Untreated Congenitally Corrected Transposition of Great Arteries
    Journal Name: CJC Open
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cjco.2021.11.004
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoring
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100145
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over time
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100126
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adq2519
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Astrocytic RNA editing regulates the host immune response to alpha-synuclein
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adp8504
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Transcriptomic responses of lung mesenchymal cells during pneumonia
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.177084
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Adult-specific Reelin expression alters striatal neuronal organization: implications for neuropsychiatric disorders
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2023.1143319
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysis
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2023.1138546
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Editorial: Brain stimulation in cognition and disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2023.1213272
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Motor Response With Apomorphine Sublingual Film and Levodopa in Patients With OFF Episodes
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/nmt-2022-0038
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.